Option chain shows key data for New Oriental Energy's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for New Oriental Energy.

New Oriental Energy (OTC:NOEC) Stock, Option Chain

NEW ORIENTAL ENERGY

New Oriental Energy & Chemical Corporation, through its subsidiary, is engaged in the manufacture and distribution of fertilizer and chemical products in the People's Republic of China.

Long Ideas

News

Short Ideas

Small Cap

Global

After-Hours Center

Movers

Trading Ideas

IFON

NOEC

SNAK

Benzinga&#39;s Microcap Movers for Thursday May 3, 2012

New Oriental Energy &amp; Chemical Corp to Delist Common Stock from NASDAQ

Trading Halted: New Oriental Energy &amp; Chemical, News Pending

NEW ORIENTAL ENGY & CHEM by New Oriental Energy & Chemical Corp.

New Oriental Energy & Chemical Corp

Below are highlights from Benzinga's daily coverage of microcap securities making big moves:

New Oriental Energy &amp; Chemical Corp

Shares of New Oriental Energy &amp; Chemical Corp (<a class="ticker" href="/stock/noec#">NOEC</a>), the China-based producer of Urea, Ammonium Bicarbonate, Methanol and DME, rose 566% Thursday on 40 times the average daily volume.

New Oriental Energy &amp; Chemical Corp. announced Thursday the completion of a Share Exchange Agreement by and among the Company and British Virgin Islands-based Anothen Recycling Company ("Anothen"). Pursuant to the Agreement, Anothen has become a wholly-owned subsidiary of NOEC and the ongoing operations of the Company are now those of the Anothen operating subsidiary, Tianjin Xingyang Package Co., Ltd. ("Xingyang"), based in Tianjin City, The People's Republic of China. Effective with the closing, Mr. Zhang Tongde, 44, Xingyang's founder, CEO and president, has been appointed Chairman of the Board of the Company.

"We experienced significant progress in 2011," Mr. Zhang Tongde said, "with record revenues, and rapid growth in particular in our recycling business. During the year, our recycled paper sector accounted for over 21.5% of our revenues for the first time, a percentage we anticipate will be higher in the current year as rapid growth in this sector continues.

New Oriental Energy &amp; Chemical Corp closed at $0.08 on Thursday.

Infosonics

Shares of Infosonics (<a class="ticker" href="/stock/ifon#">IFON</a>), the San Diego, CA provider of wireless handset solutions serving Latin America, Europe, Africa and Asia Pacific, rose 56% Thursday on 33 times the average daily volume.

InfoSonics Corporation announced Thursday results for its first quarter ended March 31, 2012.

InfoSonics reported net sales for the first quarter of 2012 of $12.4 million, which represents a 30% increase over $9.5 million for the first quarter of 2011. Gross profit in the first quarter of 2012 was $2.3 million, a 178% increase over $812,000 in the 2011 first quarter. Operating expenses in the first quarter of 2012 were $2.1 million, an increase of 16% compared to $1.8 million in the 2011 first quarter. This reflects an 11% increase in sales and marketing expenses primarily attributable to increases in personnel, commissions on higher sales volume and expenses related to new product launches. In addition, R&amp;D expenses rose by 40% as we expanded our development team and introduced more new models. Net income for the first quarter of 2012 was $105,000, or $0.01 per share, compared to a net loss of $894,000, or $0.06 per share, in the first quarter of 2011.

Infosonics closed at $1.25 on Thursday.

Inventure Foods

Shares of Inventure Foods (NASDAQ: <a class="ticker" href="/stock/snak#NASDAQ">SNAK</a>), the Phoenex, AZ specialty food marketer and manufacturer, rose 12.29% Thursday on 8 times the average daily volume. 

Inventure Foods reported Thursday record financial results for the first quarter ending March 31, 2012, highlighted by double-digit net revenue growth in both the Snack and Frozen segments and record first quarter earnings of $0.09 per fully diluted share. 
 
Inventure generated record net revenues of $47.0 million for the first quarter, an increase of 28.3%, or $10.4 million versus the prior-year first quarter, attributable to strong performance in both the Snack and Frozen segments. 

Inventure Foods closed at $4.09 on Thursday.

The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment.

Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.

Benzinga's Microcap Movers for Thursday May 3, 2012

New Oriental Energy & Chemical Corp to Delist Common Stock from NASDAQ

Trading Halted: New Oriental Energy &amp; Chemical (NASDAQ: <a class="ticker" href="/stock/noec#NASDAQ">NOEC</a>), News Pending

Trading Halted: New Oriental Energy & Chemical, News Pending

Sharesleuth.com posted a fascinating <a href="http://sharesleuth.com/investigations/2011/01/you-wont-find-s-paul/">investigative piece</a>, examining the murky world of Chinese reverse mergers. According to the article, a man named S. Paul Kelley and his partners have helped create a string of U.S.-listed Chinese companies, many of which have seen significant share price declines after initially notching big gains. 
These companies include Telestone Technologies (NASDAQ: <a class="ticker" href="/stock/tstc#NASDAQ">TSTC</a>) and Kandi Technologies Corp. (NASDAQ: <a class="ticker" href="/stock/kndi#NASDAQ">KNDI</a>). After the companies were reverse merged into listed shell companies, Kelley and his partners promoted the stock and were given millions of dollars in shares for their efforts. 
According to Sharesleuth.com, Kelley has assisted in at least 11 Chinese reverse mergers, which are listed below. Investors who are in any of these names are advised to read this report, as it is extremely detailed and exposes some of the shady practices that is taking place in the Chinese reverse merger space. 
Telestone (Nasdaq: <a class="ticker" href="/stock/tstc#Nasdaq">TSTC</a>) Telestone sells wireless communications equipment and network access packages, primarily to China's three main mobile phone companies. The Beijing-based company went public in 2004 by merging with a U.S. shell that had just reorganized in bankruptcy court.
Orsus Xelent (AMEX: <a class="ticker" href="/stock/ors#AMEX">ORS</a>) The company, which also has headquarters in Beijing, manufactures and distributes cellular telephones. Kelley helped the company gain a U.S. listing in 2005.
New Oriental Energy (Nasdaq: <a class="ticker" href="/stock/noec#Nasdaq">NOEC</a>) The company is based in Xinyang and makes fertilizer and chemical products. It went public in 2006.
Kandi (Nasdaq: <a class="ticker" href="/stock/kndi#Nasdaq">KNDI</a>) The company, which currently has headquarters in Jinhua, makes all-terrain vehicles and go carts, and is developing its own line of electric cars. Kandi became a public company in 2007.
China INSOnline (Pink Sheets: CHIO.PK) The Beijing-based company once operated a web portal offering information on insurance services. Kelley helped bring the company public in 2007. Its shares were delisted from the Nasdaq in November and now trade on the Pink Sheets.
China Auto Logistics Inc. (Nasdaq: <a class="ticker" href="/stock/cali#Nasdaq">CALI</a>) The company, which has headquarters in Tianjin, imports and sells cars. It went public through a reverse merger in 2008.
China Infrastructure Investment Corp. (Nasdaq: <a class="ticker" href="/stock/ciic#Nasdaq">CIIC</a>) The company has headquarters in Zhengzhou and owns and operates a toll road called the Pinglin Expressway. Kelley helped it get a U.S. listing in 2008.
Guanwei Recycling Corp. (Nasdaq: GPRC) Guanwei is based in Fuqing City and recycles plastic waste from Europe into polyethylene for use by Chinese manufacturers. It went public through a reverse merger last year.
Winland Online Shipping Holdings Corp. (OTCBB: WLOL.OB) The Hong Kong company operates a fleet of oceangoing vessels and offers shipping and logistics services. It became a public company in 2008.
CH Lighting International Corp. (Pink Sheets: CHHN.PK) CH Lighting is based in Shangyu City and makes fluorescent bulbs, lamps and other lighting products. The company, which once traded on the Over-the-Counter market, became public in 2008.
Chisen Electric Corp. (OTCBB: CIEC.OB) The Changxing-based company makes batteries for electric bicycles, motorcycles and cars. It became a public company in 2008.

Wall Street Journal

Small Cap Analysis

Intraday Update

Markets

Media

Personal Finance

General

CALI

CIIC

KNDI

TSTC

S. Paul Kelley: Man Behind Sketchy Chinese Reverse Mergers (TSTC, KNDI, ORS, NOEC, CALI, CIIC, GPRC) 

New Oriental Energy &amp; Chemical Corp. (NASDAQ: <a class="ticker" href="/stock/noec#NASDAQ">NOEC</a>) reported today that on Friday, August 27, 2010, the Company outlined in a letter to the NASDAQ Stock Market the steps it is undertaking to achieve compliance with NASDAQ's minimum shareholder equity requirement of $2,500,000. This letter and related attachments are contained in a Form 8-K being filed by the Company with the U.S. Securities and Exchange today. 
In the letter, management acknowledges that its stockholder equity as of June 30, 2010 of ($470,784) is below the minimum requirement for continued listing on NASDAQ. The Company goes on to describe actions being taken by management to bring the Company back into compliance.

New Oriental Energy & Chemical Corp. Responds to NASDAQ Request (NOEC)

NEW YORK, NY--(Marketwire - August 17, 2009) - New Oriental Energy &amp; Chemical Corp. (NASDAQ: NOEC) (the "Company"), a specialty chemical and emerging coal-based 
alternative fuel manufacturer in The People's Republic of China (the 
"PRC"), reported results today for its fiscal year first quarter ended June 
30, 2009.

Reflecting reduced sales volumes and lower prices for its fertilizer and 
alternative fuel products, the Company reported first quarter revenues 
declined to $8,384,866 compared with $15,595,093 in last year's first 
quarter. Further, as compared with net income in the first quarter ended 
June 30, 2008 of $828,019, or $0.07 per share, the Company incurred a loss 
of $(3,161,527), or $(0.25) per share, in the current fiscal year first 
quarter.

Since the start of its fiscal year, the Company said that demand in the 
PRC's agricultural sector for urea has increased. It noted, though, that 
the raw material for the majority of global urea is oil and, consequently, 
with sharply lower oil prices, the price of coal-based urea declined 
substantially -- from approximately $345 per ton in the Company's fourth 
quarter last year, to $253 per ton in the first quarter this year. At the 
same time, while down from its highest recent prices, during the first 
quarter this year coal in the PRC was approximately 35% more expensive than 
in the same period a year ago. Given these factors, the Company's first 
quarter urea sales were down sharply and unprofitable.

The lower cost of oil and the continuing high price of coal also affected 
sales of DME and methanol, the Company's alternative fuel products. During 
the quarter the Company said it shut down production of DME, which was a 
key contributor to revenues and profits during the Company's prior fiscal 
year, and continues to be its most significant product with respect to 
anticipated future growth.

The Company explained that, at present, the primary product DME normally 
would substitute for is liquefied petroleum gas (LPG), which is widely used 
in the PRC for home cooking and heating. However, with LPG prices down 
significantly, DME temporarily has lost its price advantage. With respect 
to methanol, current oil prices have reduced the cost of imported oil-based 
products which, in turn, has reduced coal-based methanol selling prices.

Under current circumstances, the Company said that it has delayed, for 
another three months, the planned completion of its methanol plant 
expansion -- from December this year to March of 2010. To date, the plant 
has largely been self-financed by the Company. Prior to completion, the 
Company is required to pay approximately $9 million for contracts already 
executed with certain suppliers. In connection with this the Company is 
engaged in discussions regarding outside financing, if required, and 
remains confident such financing will be available. In this regard, the 
Company's largest shareholder has committed to provide funds to the 
Company, if necessary.

A Brightening Outlook

Mr. Chen Si Qiang, CEO and Chairman of the Company, as well as its largest 
shareholder, stated, "It is apparent that we underestimated the depth of 
the current recession and the effect it would have on oil prices and the 
pricing of our key products in the first quarter. However, the signs we 
were seeing pointing to an improvement in the situation have emerged more 
clearly in recent weeks. On the cost side, we have seen coal prices 
continue to decline since March 2009, from a high of more than 70% above 
prior year prices. Spurred in part by government actions, the agricultural 
demand for urea also continues to be strong. Further, the severe 
difficulties faced by smaller domestic coal-based producers of the product 
should improve our Company's competitive position."

Legalized Methanol Use With Gasoline

"Additionally," he continued, "in late June, the Chinese government 
announced that it will officially start 
anti-dumping investigations for methanol being imported from Malaysia, 
Indonesia and Saudi Arabia which, in time, should help ease the problem. 
Perhaps of greatest significance, the government recently announced 
national standards for methanol modified gasoline which will become 
effective on November 1, 2009. Legalizing the mixing of methanol with 
gasoline should greatly increase the potential for building market demand 
for this alternative fuel and benefit our Company. While the prospects for 
DME usage -- not only as a household fuel substitute, but as a substitute 
in buses and other vehicles for diesel and gasoline -- may take somewhat 
longer to develop, we remain confident that the future of this product is 
quite bright when oil prices move up in an improving world economy."

Long and Short Term Confidence

"Despite the current environment," Mr. Chen continued, "the Company's 
potential should not be underestimated. We will continue to improve 
products and to make our processes more effective by applying our very 
strong technological skills. Our capabilities in both our traditional and 
new alternative fuel products will continue to generate a rich product 
pipeline that we believe will drive long-term growth. In our view, the 
outlook for improved results in the short term also has improved greatly 
after a very difficult period."

About New Oriental Energy &amp; Chemical Corp.

New Oriental Energy &amp; Chemical Corp., listed on the NASDAQ Global Market 
(NASDAQ: NOEC), is an emerging coal-based alternative fuels and specialty 
chemical manufacturer based in Henan Province, in the PRC. The Company's 
core products are Urea and other coal-based chemicals primarily utilized as 
fertilizers. Future growth is anticipated from its focus on expanding 
production of coal-based alternative fuels, in particular, methanol, as an 
additive to gasoline and dimethyl ether (DME), which has been a cheaper, 
more environmentally friendly alternative to LPG for home heating and 
cooking, and diesel fuel for cars and buses. All of the Company's sales are 
made through a network of distribution partners in the PRC. Additional 
information on the Company is available on its website at 
<a href="http://www.neworientalenergy.com">www.neworientalenergy.com</a>.

Safe Harbor Statement

This press release may contain forward-looking statements concerning New 
Oriental Energy &amp; Chemical Corp. The actual results may differ materially 
depending on a number of risk factors including, but not limited to, the 
following: general economic and business conditions, development, shipment, 
market acceptance, additional competition from existing and new 
competitors, changes in technology or product techniques, and various other 
factors beyond its control. All forward-looking statements are expressly 
qualified in their entirety by this Cautionary Statement and the risk 
factors detailed in the Company's reports filed with the Securities and 
Exchange Commission. New Oriental Energy &amp; Chemical Corp. undertakes no 
duty to revise or update any forward-looking statements to reflect events 
or circumstances after the date of this release.
 NEW ORIENTAL ENERGY &amp; CHEMICAL CORP. AND SUBSIDIARIES 
 CONDENSED CONSOLIDATED STATEMENTS OF (LOSS) INCOME AND 
 COMPREHENSIVE (LOSS) INCOME 
 (UNAUDITED)
 Three Months Ended 
 June 30, 
 ---------------------------- 
 2009 2008 
 ------------- --------------
REVENUES $ 8,384,866 $ 15,965,093
COST OF GOODS SOLD (9,973,189) (13,257,214) 
 ------------- --------------
GROSS (LOSS) PROFIT (1,588,323) 2,707,879
General and administrative 727,934 949,161
Selling and distribution 287,540 277,989
Research and development 27,626 20,433 
 ------------- --------------
(LOSS) INCOME FROM OPERATIONS (2,631,423) 1,460,296
OTHER EXPENSES
Interest expense, net (461,917) (186,755)
Other expenses, net (3,507) (32,167) 
 ------------- --------------
(LOSS) INCOME BEFORE INCOME TAXES (3,096,847) 1,241,374
INCOME TAX (55,008) (413,355) 
 ------------- --------------
NET (LOSS) INCOME (3,151,855) 828,019 
 ------------- --------------
OTHER COMPREHENSIVE (LOSS) INCOME
Foreign currency translation (loss) gain (9,672) 440,034 
 ------------- --------------
OTHER COMPREHENSIVE (LOSS) INCOME (9,672) 440,034 
 ------------- --------------
COMPREHENSIVE (LOSS) INCOME $ (3,161,527) $ 1,268,053 
 ============= =============
WEIGHTED AVERAGE SHARES OUTSTANDING, BASIC 
 AND DILUTED 12,640,000 12,640,000 
 ============= =============
NET (LOSS) INCOME PER SHARE, BASIC AND 
 DILUTED $ (0.25) $ 0.07 
 ============= =============

COST

First Quarter Results of New Oriental Energy and Chemical Continued to Be Impacted by Reduced Prices and High Costs for Its Coal-Based Products

1) DGW - Duoyuan Global Water Inc. - NYSE Listing 
What They Do : We are a leading China-based domestic water treatment equipment supplier. Our product offerings focus on addressing the key steps in the water treatment process, such as filtration, water softening, water-sediment separation, aeration, disinfection and reverse osmosis. Founded in 1992, we offer a comprehensive set of more than 80 complementary products across the following three product categories: • Circulating Water Treatment Equipment • Water Purification Equipment • Wastewater Treatment Equipment 
Links : <a href="http://www.sec.gov/Archives/edgar/data/1465317/000095012309010158/h03310fv1.htm">F-1 Filing</a> <a href="http://www.retailroadshow.com/sys/launch.asp?k=26863653787">Road Show Presentation</a>
The Numbers : - Float will be 5m. Outstanding will be approximately 21m. (Each ADS represents 2 ordinary shares. There will be approximately 42m ordinary shares outstanding after this deal). - Revenue growth 40% 2008 vs 2007 and 39% Q109 vs Q109. Net Income growth 63% 2008 vs 2007 and 92% Q109 vs Q109. - They did 19.5m of Net Income in FY 2008. - Expected Pricing $13-$15
super-trades summary : This is perhaps one of the sexiest sectors that exists. Water is a scare resource, especially in China. China is predicted to lead the world out of this recession. When I take the 19.5m of net income divided by the post-IPO ADS shares outstanding of 21m I get .93 trailing EPS with the company growing revenue and net income in Q109 by 39% and 92%, respectively. At $15 pricing that is about a 16 trailing P/E. Mix in a 5m float and I expect this IPO to generate strong interest. Only question is how high does it gap up. Under $20 I will try some shares. 
Sympathy plays : CLWT - Small cap play on this IPO similar business. Due to release annual report in June. I am sure those that like lower priced stocks come for this in a sympathy trade.
RINO.OB - Similar business with much better EPS and priced at what I consider to be ridiculously cheap. (Currently P/E of 4-5) Read why I think RINO.OB is a much better play than DGW. Applying the 16 P/E on RINO.OB recent EPS run rate would make it a $32 stock. <a href="http://super-trades.blogspot.com/2009/06/rinoob-amazing-growth-compare-to-coming.html">Read Blog Post</a>
2) CPC - Chemspec International - NYSE Listing 
What They Do : We are a leading China-based contract manufacturer of highly engineered specialty chemicals. In particular, we are the largest manufacturer of fluorinated specialty chemicals in China based on sales with a share of approximately 21% and 25% of the Chinese market in 2007 and 2008, respectively, according to a commissioned report prepared by Frost &amp; Sullivan. We manufacture specialty chemicals, which are typically highly engineered chemicals used as building blocks in the manufacture of more advanced chemicals or to enhance the performance of the end products manufactured by our end users in various industries including electronics, pharmaceuticals and agrochemicals.
Links : <a href="http://www.sec.gov/Archives/edgar/data/1463398/000119312509131521/df1a.htm">F-1 Filing</a> <a href="http://www.retailroadshow.com/sys/launch.asp?k=21293745131">Road Show Presentation</a>
The Numbers : - Float will be 8.1m. Outstanding will be approximately 36m. (Each ADS represents 60 ordinary shares. There will be approximately 2.1B ordinary shares outstanding after this deal). - Revenue growth 60% 2008 vs 2007 and 23% Q109 vs Q109. Net Income growth 34% 2008 vs 2007 and -44% Q109 vs Q109. - They did 45.9m of Net Income in FY 2008. - Expected Pricing $7-$9
super-trades summary : China is predicted to lead the world out of this recession. When I take the 45.9m of net income divided by the post-IPO ADS shares outstanding of 36m I get 1.28 trailing EPS. The company grew revenue by 23% in Q109, yet net income declined by 44% due to lower margins and increased R&amp;D expenses. They also mentioned a slowdown due to the global recession that they gradually see recovering. I am sure that affected the pricing range. At $9 pricing that is about a 7 trailing P/E. I need to see how well this is received, but I think a 10 P/E range would not be unreasonable for this Company. It could get a higher one if they convince investors that net income growth will continue. Would try some around the pricing range or 10% above but will not chase unless I sense it is getting interest.
Sympathy plays : CPC may not have enough interest to push some sympathy plays. However if this IPO is well received, then NOEC and SDTH are two small cap sympathy trades to watch.
3) SKBO.OB - Skystar Bio-Pharmaceutical Company - Nasdaq Listing 
What They Do : Skystar is a China-based developer and distributor of veterinary healthcare and medical care products. Skystar has four product lines (veterinary medicines, microorganisms, vaccines and feed additives) and over 170 products, with over 40 additional products in the developmental stage. Skystar has formed strategic sales distribution networks covering 29 provinces throughout China
Links : <a href="http://www.sec.gov/Archives/edgar/data/1076939/000114420409030422/v151106_s1a.htm">S-1 Filing</a> <a href="http://www.sec.gov/Archives/edgar/data/1076939/000114420409030850/v151553_fwp.htm">Company Presentation</a>
The Numbers : - Float will be approximately 1.5m. Outstanding will be approximately 3m. Company currently trades on the OTCBB and will do an IPO on the Nasdaq with the placement of 1m shares. - Revenue growth 70% 2008 vs 2007 and 42% Q109 vs Q109. Net Income growth 63% 2008 vs 2007 and 73% Q109 vs Q109.
Mind Boggling Numbers - In the S-1 filing, Skystar reported $3.07 EPS for FY 2008 and $0.57 EPS for First Quarter 2009. Revenue was up 70% in FY 2008 vs. FY 2007. Revenue was up 42% and Net Income was up 73% in the First Quarter of 2009.
More Mind Boggling Growth - From the S-1 "Manufacturing Facilities. We intend to complete a vaccine manufacturing facility with approximately $2.5 million from the net proceeds of the offering. Under our current plans, this facility is expected to be completed by the fourth quarter of 2009 and obtain GMP certification in late 2009. Once completed, we believe that this facility will increase production capacity by 6 billion units, or 2,300.0% from 250 million units, with a value of $14.0 million in projected revenue at a gross margin rate of 60-70%.
Additionally, we are planning to construct a new production facility for micro-organism and feed additives with approximately $1.5 million from the net proceeds of the offering. Under our current planning, the annual production capacity of this production facility will be approximately 4,000 metric tonnes, an increase of 48.7% from our current capacity of 8,200 metric tonnes. We anticipate construction to complete in the fourth quarter of 2009." 
By my calculations, with the addition of these two facilities the Company will have the potential to add up to $14m additional revenue at 60-70% gross margin rate from vaccines and approximately $3m in feed additives (facility increases capacity by 49% and they did $5.9m in this category in 2008 at a 65% blended gross profit margin - see Presentation). If they can produce and sell this extra capacity I calculate that as an additional $10m in gross profit. In Q1 2009 the Net Income margin was around 28%. So this extra capacity (if produced and sold successfully and at these same margins) could add another $1 EPS in 2010 by my calculations.
In 2008 (see the presentation and the S-1 they did $3.07 EPS on the shares outstanding), Skystar had $5.6m of net income that included $1.1m of non-recurring expenses, or $6.7m adjusted net income. If I divide that by the new post-IPO share count of approximately 2.9m, I get EPS of $2.31. Now, in the first quarter of 2009, net income was up 72% YOY. If the Company hypothetically can even grow net income by 30% for all of 2009 over 2008, that $2.31 would go to $3.00 EPS with the new shares offered. 
In 2010 if they have these new facilities in place and produce and sell with the above assumptions from the S-1 that would calculate to another $1 EPS. Going by my calculations, I see a scenario where if all falls into place perfectly this company could do $3+ EPS in 2009 and $4+ in 2010. (Not to mention potential growth from the many products they have awaiting approval) You can use your imagination with a 10-20 P/E ratio. Again, this is what I see as potential when I look at their numbers and information, not a prediction or guarantee.
Lastly, according to the Company website, they are also working on an Avian flu vaccine for the birds themselves. "While larger international companies are focusing on vaccines to prevent people from catching avian flu, Skystar's focus is on vaccines to be administered to farm chickens and other poultry to prevent them from catching H5N1 Avian Influenza. This type of vaccine is well within Skystar's current scope and expertise and could potentially prevent an epidemic/pandemic by controlling an outbreak at the source (the poultry)." <a href="http://www.skystarbio-pharmaceutical.com/txoperation.asp">See Website</a>
super-trades summary : This is perhaps one of the most exciting scenarios I have seen in sometime. If the Company can do $3+ EPS in 2009 then this is pricing at a P/E of 3! If DGW ends up with a P/E of 20+, applying that to $3 EPS would be a stock price of $60. With this float and amazing EPS and low valuation, if the momentum/valuation crowd shows interest, I can see this stock being one of those rare stocks that runs to the $30-$50 range like EFUT did in 2006. <a href="http://super-trades.blogspot.com/2009/06/do-not-chase-is-this-next-efut-from.html">Read Blog Post</a>
Sympathy plays : Any low float China stocks with great EPS and low valuations.
I am long SKBO.OB. This blog is my opinion and not investment advice or a prediction of future prices. 
<div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/5228867326212547264-9107441244474018475?l=super-trades.blogspot.com' alt='' /></div>

Comments

New Oriental Energy

New Oriental Energy (NOEC) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga